Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 69 Breast Neoplasms 52 Carcinoma, Non-Small-Cell Lung 29 Neoplasms 27 Myelodysplastic Syndromes 27 Advanced Solid Tumors 27 Advanced Solid Tumor 26 Prostatic Neoplasms 24 Stomach Neoplasms 19 Recurrence 19 Multiple Myeloma 19 Neoplasm Metastasis 18 Carcinoma, Hepatocellular 18 Lung Neoplasms 16 Ovarian Neoplasms 15 Pancreatic Neoplasms 14 Uterine Cervical Neoplasms 13 Solid Tumor 13 Sarcoma 13 Melanoma 13 Leukemia, Myelomonocytic, Chronic 13 Colorectal Neoplasms 12 Triple Negative Breast Neoplasms 10 Small Cell Lung Carcinoma 10 Lymphoma, Large B-Cell, Diffuse 10 Esophageal Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Myeloproliferative Disorders 8 Lymphoma, Non-Hodgkin 8 Lymphoma, B-Cell 7

Interventions

Gemcitabine 3 folfirinox 2 Oxaliplatin 2 Irinotecan 2 toripalimab 1 surufatinib 1 sintilimab 1 devimistat 1 chloroquine diphosphate 1 balstilimab 1 Taxes 1 Paclitaxel 1 Leucovorin 1 Injections 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Cisplatin 1 Chloroquine 1 Celecoxib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cancer Metastatic × Injections × Clear all

NCT06752811 2026-02-10

pompom

Shanghai Yizhong Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡